¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"B-Cell Activation Factor Receptor"¿¡ ´ëÇÑ ´ëÇÑÀÇÇù ÀÇÇпë¾î ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
beta-adrenergic receptor kinase
º£Å¸¾Æµå·¹³¯¸°¼ö¿ëüÀλêÈÈ¿¼Ò
cold receptor
³Ã°¢¼ö¿ë±â
complement receptor
º¸Ã¼¼ö¿ëü
corpuscular receptor
¼Òü¼ö¿ëü
cell surface receptor
¼¼Æ÷Ç¥¸é¼ö¿ëü
cholinergic receptor
Äݸ°¼ö¿ëü
distance receptor
¿ø°Ý¼ö¿ë±â
dominant receptor
¿ì¼º¼ö¿ëü
early receptor potential
Á¶±â¼ö¿ëüÀüÀ§, Á¶±â½Ã°¢¼¼Æ÷ÀüÀ§
estrogen receptor
¿¡½ºÆ®·Î°Õ¼ö¿ëü
free receptor
À¯¸®¼ö¿ëü
gustatory receptor
¹Ì°¢¼ö¿ë±â
H1 receptor
H1¼ö¿ëü
H2 receptor
H2¼ö¿ëü
heat receptor
¿¼ö¿ë±â
ÀÌÀü
´ÙÀ½
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
13
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
nerve growth factor
½Å°æ¼ºÀåÀÎÀÚ
platelet activating factor
Ç÷¼ÒÆÇȰ¼ºÀÎÀÚ
platelet-derived growth factor
Ç÷¼ÒÆÇÀ¯·¡¼ºÀåÀÎÀÚ, Ç÷¼ÒÆÇ±â¿ø¼ºÀåÀÎÀÚ
precipitation factor
ÃËÁø¿äÀÎ
predisposing factor
¼±Çà¿äÀÎ
prognostic factor
¿¹ÈÄÀÎÀÚ
psychological factor
½É¸®¿ä¼Ò
relaxing factor
ÀÌ¿ÏÀÎÀÚ
resistance factor
³»¼ºÀÎÀÚ, °ßµõÀÎÀÚ
rheumatoid factor
·ù¸¶Æ¼½ºÀÎÀÚ
risk factor
À§ÇèÀÎÀÚ
transforming growth factor
Àüȯ¼ºÀåÀÎÀÚ
vascular endothelial growth factor
Ç÷°ü³»ÇǼºÀåÀÎÀÚ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
antigen binding receptor
Ç׿ø°áÇÕ¼ö¿ëü
receptor autoradiography
¼ö¿ëüÀÚ°¡¹æ»ç¼±¼ú
beta-adrenergic receptor kinase
º£Å¸¾Æµå·¹³¯¸°¼º¼ö¿ëüÀλêÈÈ¿¼Ò
receptor binding
¼ö¿ëü°áÇÕ
receptor blocker
¼ö¿ëüÂ÷´ÜÁ¦
cell surface receptor
¼¼Æ÷Ç¥¸é¼ö¿ëü
cholinergic receptor
Äݸ°¼ö¿ëü
cold receptor
³Ã°¢¼ö¿ëü
complement receptor
µµ¿òü¼ö¿ëü, º¸Ã¼¼ö¿ëü
corpuscular receptor
¼Òü¼ö¿ëü
receptor cell
¼ö¿ëü¼¼Æ÷
distance receptor
(¢¡teleceptor) ¿ø°Ý¼ö¿ëü
dominant receptor
¿ì¼º¼ö¿ëü
early receptor potential
Á¶±â½Ã°¢¼¼Æ÷ÀüÀ§
electromagnetic receptor
ÀüÀÚ±â¼ö¿ëü
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
polyclonal activation
´Ù(¼ö)Ŭ·ÐȰ¼º, ¿©·¯¹«¸®È°¼º
A1 receptor
A1 ¼ö¿ëü(¼ö¿ë±â, °¨¼ö±â)
A2 receptor
A2 ¼ö¿ëü(¼ö¿ë±â, °¨¼ö±â)
CR1 => complement receptor 1
º¸Ã¼¼ö¿ëü 1
CR2 => complement receptor 2
º¸Ã¼¼ö¿ëü 2
CR3 => complement receptor 3
º¸Ã¼¼ö¿ëü 3
CR4 => complement receptor 4
º¸Ã¼¼ö¿ëü 4
Gustatory receptor
¹Ì°¢¼ö¿ëü(Ú«ÊÆâ¥é»ô÷)
H2 receptor antagonist
H2 ¼ö¿ëü ±æÇ×Á¦µé
Ig receptor
¸é¿ª±Û·ÎºÒ¸° ¼ö¿ëü
Internalization, receptor
³»È(Ò®ü§), ¼ö¿ëü(áôé»ô÷)
Kainate amino acid receptor
Ä«À̳×ÀÌÆ® ¾Æ¹Ì³ë»ê ¼ö¿ëü(áôé»ô÷)
Kinesthetic receptor
¿îµ¿(ê¡ÔÑ)(°¨(Êï))°¢¼ö¿ëü(ÊÆáôé»ô÷)
NMDA receptor
¿£¾Úµð¿¡ÀÌ ¼ö¿ëü
T cell receptor
T¼¼Æ÷[Ç׿ø]¼ö¿ëü
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
heat of activation
Ȱ¼ºÈ¿(üÀàõûýæð)
macrophage,activation of
Ȱ¼ºÈ(üÀàõûù)
neutron activation analysis
Áß¼ºÀÚ¹æ»çȺм®(~Û¯ÞÒûùÝÂà°).
photochemical activation
±¤È°¼ºÈ(Ë´Ì· ËÛÌ´).
plasmin activation inhibitor
Çö󽺹ÎȰ¼ºÈ¾ïÁ¦Á¦(¡üÀàõûùåäð¤ð¥)
polyclonal B cell activation
B¼¼Æ÷ ´Ù(¼ö)Ŭ·ÐȰ¼º, B¼¼Æ÷ ¿©·¯¹«¸®È°¼º
polyclonal activation
´Ù(¼ö)Ŭ·ÐȰ¼º, ¿©·¯¹«¸®È°¼º
sleep activation
¼ö¸éºÎȰ(¹ý)(¡Ý¥üÀÛö) ³úÆÄ(Òà÷î)ÀÇ .
thermal activation
¿È°¼ºÈ¹ÝÀÀ(æðüÀàõûù Úãëë).
tissue plasminogen activation
Á¶Á÷ ÇöóÁî¹Ì°Õ Ȱ¼º
tissue plasminogen activation inhibitor
Á¶Á÷ ÇöóÁî¹Ì³ë°Õ Ȱ¼º ¾ïÁ¦ÀÎÀÚ
trypsinogen activation peptide(TAP)
ventricular activation
½É½ÇÈïºÐ(ãýãøýéÝÇ).
ventricular activation
½É½ÇÈïºÐ(ãýãøýéÝÇ)
ventricular activation time
½É½ÇÈïºÐ½Ã°£(ãýãøýéÝÇãÁÊà).
ÀÌÀü
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
ÅëÇÕ°Ë»ö ¿Ï·á
ÀÌÀü
´ÙÀ½